Apyx shareholder alert: jakubowitz law reminds apyx shareholders of a lead plaintiff deadline of august 5, 2022

New york , july 29, 2022 /prnewswire/ -- jakubowitz law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of apyx medical corporation (nasdaq: apyx). to receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/apyx-medical-corporation-loss-submission-form/?id=30343&from=4 the lawsuit seeks to recover losses for shareholders who purchased apyx between may 12, 2021 and march 11, 2022.
APYX Ratings Summary
APYX Quant Ranking